Global Ophthalmology Drugs Market Professional Survey Report 2017

November 2017 | 104 pages | ID: GB1CEDF8668EN
QYResearch

Abstracts

This report studies Ophthalmology Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Novartis
• Regeneron
• Roche
• Bayer
• Allergan
• Shire
• Mallinckrodt

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Lucentis (ranibizumab)
• Eylea (aflibercept)
• Avastin (bevacizumab)
• Restasis (cyclosporine)
• Alphagan (brimonidine tartrate)
• Lumigan (bimatoprost)
• Xalatan (latanoprost

By Application, the market can be split into

• Chorioretinitis
• Choroiditis
• Retinitis
• Others

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Ophthalmology Drugs Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF OPHTHALMOLOGY DRUGS

1.1 Definition and Specifications of Ophthalmology Drugs
  1.1.1 Definition of Ophthalmology Drugs
  1.1.2 Specifications of Ophthalmology Drugs
1.2 Classification of Ophthalmology Drugs
  1.2.1 Lucentis (ranibizumab)
  1.2.2 Eylea (aflibercept)
  1.2.3 Avastin (bevacizumab)
  1.2.4 Restasis (cyclosporine)
  1.2.5 Alphagan (brimonidine tartrate)
  1.2.6 Lumigan (bimatoprost)
  1.2.7 Xalatan (latanoprost
1.3 Applications of Ophthalmology Drugs
  1.3.1 Chorioretinitis
  1.3.2 Choroiditis
  1.3.3 Retinitis
  1.3.4 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF OPHTHALMOLOGY DRUGS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Ophthalmology Drugs
2.3 Manufacturing Process Analysis of Ophthalmology Drugs
2.4 Industry Chain Structure of Ophthalmology Drugs

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF OPHTHALMOLOGY DRUGS

3.1 Capacity and Commercial Production Date of Global Ophthalmology Drugs Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Ophthalmology Drugs Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Ophthalmology Drugs Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Ophthalmology Drugs Major Manufacturers in 2016

4 GLOBAL OPHTHALMOLOGY DRUGS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Ophthalmology Drugs Capacity and Growth Rate Analysis
  4.2.2 2016 Ophthalmology Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Ophthalmology Drugs Sales and Growth Rate Analysis
  4.3.2 2016 Ophthalmology Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Ophthalmology Drugs Sales Price
  4.4.2 2016 Ophthalmology Drugs Sales Price Analysis (Company Segment)

5 OPHTHALMOLOGY DRUGS REGIONAL MARKET ANALYSIS

5.1 North America Ophthalmology Drugs Market Analysis
  5.1.1 North America Ophthalmology Drugs Market Overview
  5.1.2 North America 2012-2017E Ophthalmology Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Ophthalmology Drugs Sales Price Analysis
  5.1.4 North America 2016 Ophthalmology Drugs Market Share Analysis
5.2 China Ophthalmology Drugs Market Analysis
  5.2.1 China Ophthalmology Drugs Market Overview
  5.2.2 China 2012-2017E Ophthalmology Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Ophthalmology Drugs Sales Price Analysis
  5.2.4 China 2016 Ophthalmology Drugs Market Share Analysis
5.3 Europe Ophthalmology Drugs Market Analysis
  5.3.1 Europe Ophthalmology Drugs Market Overview
  5.3.2 Europe 2012-2017E Ophthalmology Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Ophthalmology Drugs Sales Price Analysis
  5.3.4 Europe 2016 Ophthalmology Drugs Market Share Analysis
5.4 Southeast Asia Ophthalmology Drugs Market Analysis
  5.4.1 Southeast Asia Ophthalmology Drugs Market Overview
  5.4.2 Southeast Asia 2012-2017E Ophthalmology Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Ophthalmology Drugs Sales Price Analysis
  5.4.4 Southeast Asia 2016 Ophthalmology Drugs Market Share Analysis
5.5 Japan Ophthalmology Drugs Market Analysis
  5.5.1 Japan Ophthalmology Drugs Market Overview
  5.5.2 Japan 2012-2017E Ophthalmology Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Ophthalmology Drugs Sales Price Analysis
  5.5.4 Japan 2016 Ophthalmology Drugs Market Share Analysis
5.6 India Ophthalmology Drugs Market Analysis
  5.6.1 India Ophthalmology Drugs Market Overview
  5.6.2 India 2012-2017E Ophthalmology Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Ophthalmology Drugs Sales Price Analysis
  5.6.4 India 2016 Ophthalmology Drugs Market Share Analysis

6 GLOBAL 2012-2017E OPHTHALMOLOGY DRUGS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Ophthalmology Drugs Sales by Type
6.2 Different Types of Ophthalmology Drugs Product Interview Price Analysis
6.3 Different Types of Ophthalmology Drugs Product Driving Factors Analysis
  6.3.1 Lucentis (ranibizumab) of Ophthalmology Drugs Growth Driving Factor Analysis
  6.3.2 Eylea (aflibercept) of Ophthalmology Drugs Growth Driving Factor Analysis
  6.3.3 Avastin (bevacizumab) of Ophthalmology Drugs Growth Driving Factor Analysis
  6.3.4 Restasis (cyclosporine) of Ophthalmology Drugs Growth Driving Factor Analysis
  6.3.5 Alphagan (brimonidine tartrate) of Ophthalmology Drugs Growth Driving Factor Analysis
  6.3.6 Lumigan (bimatoprost) of Ophthalmology Drugs Growth Driving Factor Analysis
  6.3.7 Xalatan (latanoprost of Ophthalmology Drugs Growth Driving Factor Analysis

7 GLOBAL 2012-2017E OPHTHALMOLOGY DRUGS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Ophthalmology Drugs Consumption by Application
7.2 Different Application of Ophthalmology Drugs Product Interview Price Analysis
7.3 Different Application of Ophthalmology Drugs Product Driving Factors Analysis
  7.3.1 Chorioretinitis of Ophthalmology Drugs Growth Driving Factor Analysis
  7.3.2 Choroiditis of Ophthalmology Drugs Growth Driving Factor Analysis
  7.3.3 Retinitis of Ophthalmology Drugs Growth Driving Factor Analysis
  7.3.4 Others of Ophthalmology Drugs Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF OPHTHALMOLOGY DRUGS

8.1 Novartis
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Novartis 2016 Ophthalmology Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Novartis 2016 Ophthalmology Drugs Business Region Distribution Analysis
8.2 Regeneron
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Regeneron 2016 Ophthalmology Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Regeneron 2016 Ophthalmology Drugs Business Region Distribution Analysis
8.3 Roche
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Roche 2016 Ophthalmology Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Roche 2016 Ophthalmology Drugs Business Region Distribution Analysis
8.4 Bayer
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Bayer 2016 Ophthalmology Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Bayer 2016 Ophthalmology Drugs Business Region Distribution Analysis
8.5 Allergan
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Allergan 2016 Ophthalmology Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Allergan 2016 Ophthalmology Drugs Business Region Distribution Analysis
8.6 Shire
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Shire 2016 Ophthalmology Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Shire 2016 Ophthalmology Drugs Business Region Distribution Analysis
8.7 Mallinckrodt
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Mallinckrodt 2016 Ophthalmology Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Mallinckrodt 2016 Ophthalmology Drugs Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF OPHTHALMOLOGY DRUGS MARKET

9.1 Global Ophthalmology Drugs Market Trend Analysis
  9.1.1 Global 2017-2022 Ophthalmology Drugs Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Ophthalmology Drugs Sales Price Forecast
9.2 Ophthalmology Drugs Regional Market Trend
  9.2.1 North America 2017-2022 Ophthalmology Drugs Consumption Forecast
  9.2.2 China 2017-2022 Ophthalmology Drugs Consumption Forecast
  9.2.3 Europe 2017-2022 Ophthalmology Drugs Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Ophthalmology Drugs Consumption Forecast
  9.2.5 Japan 2017-2022 Ophthalmology Drugs Consumption Forecast
  9.2.6 India 2017-2022 Ophthalmology Drugs Consumption Forecast
9.3 Ophthalmology Drugs Market Trend (Product Type)
9.4 Ophthalmology Drugs Market Trend (Application)

10 OPHTHALMOLOGY DRUGS MARKETING TYPE ANALYSIS

10.1 Ophthalmology Drugs Regional Marketing Type Analysis
10.2 Ophthalmology Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Ophthalmology Drugs by Region
10.4 Ophthalmology Drugs Supply Chain Analysis

11 CONSUMERS ANALYSIS OF OPHTHALMOLOGY DRUGS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL OPHTHALMOLOGY DRUGS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Ophthalmology Drugs
Table Product Specifications of Ophthalmology Drugs
Table Classification of Ophthalmology Drugs
Figure Global Production Market Share of Ophthalmology Drugs by Type in 2016
Figure Lucentis (ranibizumab) Picture
Table Major Manufacturers of Lucentis (ranibizumab)
Figure Eylea (aflibercept) Picture
Table Major Manufacturers of Eylea (aflibercept)
Figure Avastin (bevacizumab) Picture
Table Major Manufacturers of Avastin (bevacizumab)
Figure Restasis (cyclosporine) Picture
Table Major Manufacturers of Restasis (cyclosporine)
Figure Alphagan (brimonidine tartrate) Picture
Table Major Manufacturers of Alphagan (brimonidine tartrate)
Figure Lumigan (bimatoprost) Picture
Table Major Manufacturers of Lumigan (bimatoprost)
Figure Xalatan (latanoprost Picture
Table Major Manufacturers of Xalatan (latanoprost
Table Applications of Ophthalmology Drugs
Figure Global Consumption Volume Market Share of Ophthalmology Drugs by Application in 2016
Figure Chorioretinitis Examples
Table Major Consumers in Chorioretinitis
Figure Choroiditis Examples
Table Major Consumers in Choroiditis
Figure Retinitis Examples
Table Major Consumers in Retinitis
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Ophthalmology Drugs by Regions
Figure North America Ophthalmology Drugs Market Size (Million USD) (2012-2022)
Figure China Ophthalmology Drugs Market Size (Million USD) (2012-2022)
Figure Europe Ophthalmology Drugs Market Size (Million USD) (2012-2022)
Figure Southeast Asia Ophthalmology Drugs Market Size (Million USD) (2012-2022)
Figure Japan Ophthalmology Drugs Market Size (Million USD) (2012-2022)
Figure India Ophthalmology Drugs Market Size (Million USD) (2012-2022)
Table Ophthalmology Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Ophthalmology Drugs in 2016
Figure Manufacturing Process Analysis of Ophthalmology Drugs
Figure Industry Chain Structure of Ophthalmology Drugs
Table Capacity and Commercial Production Date of Global Ophthalmology Drugs Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Ophthalmology Drugs Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Ophthalmology Drugs Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Ophthalmology Drugs Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Ophthalmology Drugs 2012-2017
Figure Global 2012-2017E Ophthalmology Drugs Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Ophthalmology Drugs Market Size (Value) and Growth Rate
Table 2012-2017E Global Ophthalmology Drugs Capacity and Growth Rate
Table 2016 Global Ophthalmology Drugs Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Ophthalmology Drugs Sales (K Pcs) and Growth Rate
Table 2016 Global Ophthalmology Drugs Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Ophthalmology Drugs Sales Price (USD/Pcs)
Table 2016 Global Ophthalmology Drugs Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Ophthalmology Drugs 2012-2017E
Figure North America 2012-2017E Ophthalmology Drugs Sales Price (USD/Pcs)
Figure North America 2016 Ophthalmology Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Ophthalmology Drugs 2012-2017E
Figure China 2012-2017E Ophthalmology Drugs Sales Price (USD/Pcs)
Figure China 2016 Ophthalmology Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Ophthalmology Drugs 2012-2017E
Figure Europe 2012-2017E Ophthalmology Drugs Sales Price (USD/Pcs)
Figure Europe 2016 Ophthalmology Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Ophthalmology Drugs 2012-2017E
Figure Southeast Asia 2012-2017E Ophthalmology Drugs Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Ophthalmology Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Ophthalmology Drugs 2012-2017E
Figure Japan 2012-2017E Ophthalmology Drugs Sales Price (USD/Pcs)
Figure Japan 2016 Ophthalmology Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Ophthalmology Drugs 2012-2017E
Figure India 2012-2017E Ophthalmology Drugs Sales Price (USD/Pcs)
Figure India 2016 Ophthalmology Drugs Sales Market Share
Table Global 2012-2017E Ophthalmology Drugs Sales (K Pcs) by Type
Table Different Types Ophthalmology Drugs Product Interview Price
Table Global 2012-2017E Ophthalmology Drugs Sales (K Pcs) by Application
Table Different Application Ophthalmology Drugs Product Interview Price
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis Ophthalmology Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Novartis Ophthalmology Drugs Business Region Distribution
Table Regeneron Information List
Table Product A Overview
Table Product B Overview
Table 2016 Regeneron Ophthalmology Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Regeneron Ophthalmology Drugs Business Region Distribution
Table Roche Information List
Table Product A Overview
Table Product B Overview
Table 2015 Roche Ophthalmology Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Roche Ophthalmology Drugs Business Region Distribution
Table Bayer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bayer Ophthalmology Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Bayer Ophthalmology Drugs Business Region Distribution
Table Allergan Information List
Table Product A Overview
Table Product B Overview
Table 2016 Allergan Ophthalmology Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Allergan Ophthalmology Drugs Business Region Distribution
Table Shire Information List
Table Product A Overview
Table Product B Overview
Table 2016 Shire Ophthalmology Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Shire Ophthalmology Drugs Business Region Distribution
Table Mallinckrodt Information List
Table Product A Overview
Table Product B Overview
Table 2016 Mallinckrodt Ophthalmology Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Mallinckrodt Ophthalmology Drugs Business Region Distribution
Figure Global 2017-2022 Ophthalmology Drugs Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Ophthalmology Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Ophthalmology Drugs Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Ophthalmology Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Ophthalmology Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Ophthalmology Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Ophthalmology Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Ophthalmology Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Ophthalmology Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Ophthalmology Drugs by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Ophthalmology Drugs by Application 2017-2022
Table Traders or Distributors with Contact Information of Ophthalmology Drugs by Region